IP Library Granted Patent US 8,877,112
Granted Patent B2
US 8,877,112 · App. 14/146,179 · Granted Nov 4, 2014

Modular fabrication systems and methods

Inventors: Lawrence Bonassar (Ithaca, NY); Hod Lipson (Ithaca, NY); Daniel L. Cohen (Ithaca, NY); Evan Malone (Ithaca, NY)
Assignee: Cornell Research Foundation, Inc.
A61L27/36B29C67/0055
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,877,112
App. No.
14/146,179
Granted
Nov 4, 2014
Kind
B2
Abstract

The present invention relates to an article fabrication system having a plurality of material deposition tools containing one or more materials useful in fabricating the article, and a material deposition device having a tool interface for receiving one of the material deposition tools. A system controller is operably connected to the material deposition device to control operation of the material deposition device. Also disclosed is a method of fabricating an article using the system of the invention and a method of fabricating a living three-dimensional structure.

Claims (26)

1. A method of fabricating a living three-dimensional structure, said method comprising:

providing a data set representing a living three-dimensional structure to be fabricated;

providing a printable composition comprising a hydrogel seeded with cells, wherein the hydrogel comprises collagen; and

printing the printable composition onto a substrate in layers in a pattern in accordance with the data set suitable to fabricate the living three-dimensional structure without the need to provide a negative template;

wherein the printable composition is capable of (i) bonding between printed layers, (ii) holding its shape against gravity, and (iii) cross-linking slowly enough to prevent cell and material shearing during printing; and

wherein 94±5% of the cells in the fabricated living three-dimensional structure are viable.

2. The method according to claim 1 , wherein the hydrogel further comprises chitosan, fibrin, hyaluronic acid, carrageenan, polyethylene oxide, polypropylene oxide, polyethylene oxide-co-polypropylene oxide, hydroxypropyl methyl cellulose, polypropylene fumarate-co-ethylene glycol), poly(ethylene glycol)-co-poly(lactic acid), poly(vinyl alcohol), KDL12 oligopeptides, or poly(n-isopropyl acrylamide).

3. The method according to claim 1 , wherein the hydrogel further comprises a cross-linking compound.

4. The method according to claim 1 , wherein the cells are of a single cell type.

5. The method according to claim 4 , wherein the cells are chondrocytes.

6. The method according to claim 1 , wherein the cells are of more than one cell type.

7. The method according to claim 1 , wherein said printing is carried out under sterile conditions.

8. The method according to claim 7 , wherein said printing is carried out in a hermetically sealed envelope.

9. The method according to claim 1 , wherein the data set comprises geometry and cell distribution data of the structure to be fabricated, the method further comprising:

programming a system controller with instructions effective to cause said printing to produce a living three-dimensional structure with a desired geometry and cell distribution.

10. The method according to claim 9 , wherein the geometry is free-form.

11. The method according to claim 9 , wherein the geometry is an anatomic shape.

12. The method according to claim 11 , wherein the anatomic shape is patient-specific.

13. The method according to claim 1 , wherein the data set is generated by a computerized scan of a tissue/organ.

14. The method according to claim 13 , wherein the computerized scan is achieved by computerized tomography and magnetic resonance imaging.

15. The method according to claim 1 further comprising:

incubating the living three-dimensional structure under conditions effective to grow the cells.

16. The method according to claim 1 , wherein the composition is printed from a syringe.

17. The method according to claim 1 , wherein the composition is printed from a deposition tool with an accuracy and repeatability of ±25 μm.

18. The method according to claim 1 , wherein said printing is carried out at a maximum applied pressure of 1592 kPa.

19. The method according to claim 1 , wherein said printing is carried out at a maximum volumetric flow of 10.5 mL/s.

Continuity (5)
Continuation 13052787 · Mar 21, 2011
Continuation 11201057 · Aug 10, 2005
Provisional Application 60704299 · Aug 1, 2005
Provisional Application 60600529 · Aug 11, 2004
Related Publication 20140117586A1 · May 1, 2014